Arcellx Inc (NASDAQ: ACLX) on Monday, plunged -3.47% from the previous trading day, before settling in for the closing price of $67.96. Within the past 52 weeks, ACLX’s price has moved between $47.88 and $107.37.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -0.43% over the last five years. The company achieved an average annual earnings per share of -53.05%. With a float of $40.30 million, this company’s outstanding shares have now reached $54.29 million.
The firm has a total of 163 workers. Let’s measure their productivity. In terms of profitability, gross margin is 98.09%, operating margin of -127.46%, and the pretax margin is -97.54%.
Arcellx Inc (ACLX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Arcellx Inc is 26.65%, while institutional ownership is 82.10%. The most recent insider transaction that took place on Mar 18 ’25, was worth 107,460. In this transaction Director of this company sold 1,500 shares at a rate of $71.64, taking the stock ownership to the 0 shares. Before that another transaction happened on Feb 26 ’25, when Company’s insider sold 38,300 for $62.02, making the entire transaction worth $2,375,517. This insider now owns 149,186 shares in total.
Arcellx Inc (ACLX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.79 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -53.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -9.56% during the next five years compared to -31.14% drop over the previous five years of trading.
Arcellx Inc (NASDAQ: ACLX) Trading Performance Indicators
Arcellx Inc (ACLX) is currently performing well based on its current performance indicators. A quick ratio of 4.78 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 33.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.99, a number that is poised to hit -0.76 in the next quarter and is forecasted to reach -2.44 in one year’s time.
Technical Analysis of Arcellx Inc (ACLX)
Analysing the last 5-days average volume posted by the [Arcellx Inc, ACLX], we can find that recorded value of 0.53 million was lower than the volume posted last year of 0.65 million. As of the previous 9 days, the stock’s Stochastic %D was 23.00%. Additionally, its Average True Range was 3.55.
During the past 100 days, Arcellx Inc’s (ACLX) raw stochastic average was set at 16.79%, which indicates a significant decrease from 35.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.97% in the past 14 days, which was lower than the 52.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $66.94, while its 200-day Moving Average is $72.56. Now, the first resistance to watch is $67.59. This is followed by the second major resistance level at $69.58. The third major resistance level sits at $72.79. If the price goes on to break the first support level at $62.39, it is likely to go to the next support level at $59.18. Now, if the price goes above the second support level, the third support stands at $57.19.
Arcellx Inc (NASDAQ: ACLX) Key Stats
Market capitalization of the company is 3.60 billion based on 54,944K outstanding shares. Right now, sales total 107,940 K and income totals -107,350 K. The company made 15,270 K in profit during its latest quarter, and -47,080 K in sales during its previous quarter.
